Write an account on the prevalence of sickle cell disease among the tribal populations of India. What are the initiatives undertaken by the affected states to tackle with this disease ?
15 marks · directive: Write an account
The core of a good answer
Sickle cell disease, an inherited haemoglobin disorder caused by the HbS mutation, is concentrated among tribal populations in endemic belts of central, western and southern India; states such as Gujarat, Maharashtra and Chhattisgarh ran screening and care programmes, now unified under the National Sickle Cell Anaemia Elimination Mission launched in 2023.
An outline written by upsc.help, not an official UPSC answer; every fact checked by a separate review. How we work
What the question asks
The answer has two parts: the genetics and distribution of the disease among tribal groups, and the state-level and national initiatives. It should use data where available and evaluate the response.
Answer outline
Introduction
Sickle cell disease results from a single nucleotide mutation in the beta-globin gene (glutamic acid replaced by valine at position 6), inherited in an autosomal recessive manner; carriers (HbAS) are largely healthy while people with two copies suffer anaemia, pain crises and infections.
Prevalence among tribal populations
- The national mission initially covers 17 states with higher prevalence: Gujarat, Maharashtra, Rajasthan, Madhya Pradesh, Jharkhand, Chhattisgarh, West Bengal, Odisha, Tamil Nadu, Telangana, Andhra Pradesh, Karnataka, Assam, Uttar Pradesh, Kerala, Bihar and Uttarakhand.
- Prevalence reaches 9.4 to 22.2 per cent in endemic areas of Madhya Pradesh, Rajasthan and Chhattisgarh.
- Gujarat's programme screened about 92 lakh tribal people and found 7,29,561 carriers (about 7.9 per cent) and 29,584 patients (about 0.3 per cent).
- High frequency is linked to malaria: carriers are less likely to suffer severe falciparum malaria, so the allele persists in malaria-endemic regions (balanced polymorphism).
State initiatives
- Gujarat: Sickle Cell Anaemia Control Programme from 2006, begun in 5 districts and extended to 12, with treatment for patients and marriage and prenatal counselling for carriers; the state received the Prime Minister's Civil Services Award for it in 2011.
- Maharashtra and Chhattisgarh: centres for diagnosis, counselling and management set up with the National Rural Health Mission.
- Madhya Pradesh: Shahdol hosted the launch of the national mission on 1 July 2023.
National framework
- Announced in the Union Budget and launched by the Prime Minister at Shahdol on 1 July 2023, covering 278 districts in 17 states.
- Target: screen about 7 crore people aged 0 to 40, mostly in tribal areas, and issue colour-coded cards by 2025-26; vision to eliminate sickle cell disease as a public health problem before 2047.
- Three pillars: health promotion with pre-marital genetic counselling; prevention through universal screening and early detection; and holistic management and continuum of care at primary, secondary and tertiary levels.
- Hydroxyurea, which reactivates foetal haemoglobin production, is a first-line therapy that reduces the number and severity of crises.
Gaps
- Stigma around carrier status in marriage, follow-up after screening and specialist care in remote areas are the main practical challenges for programmes of this kind.
Conclusion
Tribal sickle cell disease is both a genetic and a social problem; screening must be matched with counselling sensitive to tribal marriage norms and with reliable care at the primary level.
Examples and data to cite
- Gujarat Sickle Cell Anaemia Control Programme, started 2006.
- National Sickle Cell Anaemia Elimination Mission, launched 1 July 2023, Shahdol, Madhya Pradesh.
- Mission target: about 7 crore people aged 0 to 40 screened by 2025-26 in 278 districts of 17 states.
Facts to remember
- Mutation: HbS, valine for glutamic acid at the sixth position of beta-globin.
- Inheritance: autosomal recessive; two carrier parents have a one in four chance of an affected child.
- Malaria hypothesis: heterozygote advantage maintains the allele.